BioNTech SE is 17.6x more valuable than Hemab Therapeutics Holdings, Inc. by market capitalization ($22.18 B vs $1.26 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | COAG | BNTX |
|---|---|---|
| Market cap | $1.26 B | $22.18 B |
| US-listed rank | #2478 | #582 |
| SEC filings | 38 | 548 |
BioNTech SE is 17.6x more valuable than Hemab Therapeutics Holdings, Inc. by market capitalization ($22.18 B vs $1.26 B).
Full pages: Hemab Therapeutics Holdings, Inc. and BioNTech SE, or browse the full rankings.